Presentamos el caso de una paciente de 44 años estudiada por amenorrea e hiperprolactinemia. No refería galactorrea, cefalea ni alteraciones en la visión. HIPERPROLACTINEMIA Y PROLACTINOMA. MP Diagnóstico específico: PRL se deben medir en todo paciente con hipogonadismo o. A hiperprolactinemia causa hipogonadismo hipogonadotrófico principalmente por inibir a secreção pulsátil do GnRH, além de inibir diretamente a.

Author: Aralar Shakree
Country: Qatar
Language: English (Spanish)
Genre: Software
Published (Last): 19 December 2015
Pages: 40
PDF File Size: 15.23 Mb
ePub File Size: 7.66 Mb
ISBN: 467-3-20894-410-5
Downloads: 13916
Price: Free* [*Free Regsitration Required]
Uploader: Vim

Comparative effects of bromocriptine and cabergoline on serum prolactin levels, liver and kidney function tests in hyperprolactinemic women.

Trans Am Clin Climatol Assoc. However, it is not clear if this translates into clinical benefits.

Patterns of visual loss associated with pituitary macroadenomas. Clinical characteristics and therapeutic responses in patients with germ-line Pro mutations and pituitary adenomas: Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. Temozolomide in the management of dopamine agonist-resistant prolactinomas. Ribeiro RS, Abucham J.


Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay. In the cases of microprolactinomas and intrasselar macroprolactinomas, the treatment with dopaminergic agonists may be suspended after pregnancy is confirmed. A paciente deve ser monitorada clinicamente a cada trimestre.

There was a problem providing the content you requested

Radiotherapy for prolactin-secreting pituitary tumors. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. Cabergoline and bromocriptine are among the most commonly used drugs to treat prolactinoma. Colao A, Loche S.

Diagnosis and treatment of hyperprolactinemia: Potential cardiac valve effects of dopamine agonists in hyperprolactinemia.

A study of patients with histologically verified non-functioning pituitary macroadenoma. Para un estudio no se especifican dosis de cabergolina y bromocriptina en ninguna de las revisiones identificadas [11]. J Clin Endocrinol Metab. Emotional aspects of hyperprolactinemia. Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy. Body fat in men with prolactinoma.

Se houver um crescimento significativo do tumor, deve-se reintroduzir o AD. Sobre los desenlaces incluidos en este resumen.


[Current diagnosis and treatment of hyperprolactinemia].

Prospective study of high-dose cabergoline treatment of prolactinomas in patients. Nos macroprolactinomas, o manejo deve ser individualizado. Hyperprolactinemia is a frequent neuroendocrinological condition that should be approached in an orderly and integral fashion, starting with a complete clinical history. Prolactin receptor gene expression and immunolocalization of the prolactin receptor in human luteinized granulose cells.

Cabergoline Comparative Study Group. Cabergoline Comparative Study Group. High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. Quality of life is decreased in female patients treated for microprolactinoma. Spontaneous and medically induced cerebrospinal fluidleakage in the setting of ajenorrea adenomas: Vertebral body bonemineral content in hyperprolactinemic women.

Prolactinomas are the most common pituitary adenomas that affect young women at fertile age.

Posted in Sex